CCT6A, a Novel Prognostic Biomarker for Ewing's Sarcoma

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Ewing's sarcoma (ES) is the second most prevalent malignancy among bone tissue tumors, and there is no adequate prognosis biomarker. The protein encoded by CCT6A is a molecular chaperone. Early studies have suggested that CCT6A is involved in the development of many cancers, however, there is no clear evidence of a role for CCT6A in ES.<bold>Methods</bold>: In t...

Topics

Open a Topic to create a Post that cites this publication.

• Cancer-related molecular mechanisms research
• Cardiac tumors and thrombi
• Ferroptosis and cancer prognosis
• Heat shock proteins research
• Lymphoma Diagnosis and Treatment
• Protein Degradation and Inhibitors
• Sarcoma Diagnosis and Treatment
• Vascular Tumors and Angiosarcomas

Identifiers and source

Literature Corpus work

45d550c8-d86f-5c6f-b7f8-ee3e37ef62ff

DOI

10.21203/rs.3.rs-52492/v1